Enhance your practice with CME and tools that focus on the management of neurological conditions.
Updates in MS Care: Key Topics at AAN 2026
Aaron Miller, MD
Challenging the Status Quo in Schizophrenia Treatment
Shelina Ramnarine, PhD
Stephen Marder, MD
Nutrition and the Gut-Brain Connection in Schizophrenia
Deanna L. Kelly, PharmD, BCPP
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Shared Goals, Shared Gains: Align With Patient Preferences
Turning Flares Into Function: Flag Uncontrolled Disease
When to Begin FcRn: Initiation Criteria, Key Evidence
The IgG Clock: Redose Using IgG Kinetics
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Minimal By Design: Define MSE Endpoints
The 2-Point Signal: Apply ≥2-Point Rule
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
Miami Beach, Florida
Addressing Social and Systemic Barriers in Schizophrenia
Margaret Emerson, DNP, APRN, PMHNP-BC
Depression as a Signal of MS Progression
Emerging Serum microRNAs as Early Signals in MS
Family Planning in Patients with Multiple Sclerosis
The Social Brain in Schizophrenia
Michael Green, PhD
Advancing Pediatric MS Care: Insights from AAN 2026
Elizabeth Wilson, MD
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
Early ALS Patients Show Slowed Decline with Pridopidine Treatment
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.